Type 1 diabetes is characterized by the profound destruction of the 2 insulin-producing β cells of the islets of the pancreas, thus requiring lifetime 3 endogenous insulin replenishment. Despite recent advances in diabetes care, 4 various life-threatening complications, including cardiovascular disease, 5 neuropathy and renal failure, can result in affected patients. 6 Pancreatic islet transplantation is now a promising treatment for type 1 7 diabetic patients. However, it still has some issues to overcome. For example, 8 an individual diabetic patient usually requires islets from multiple donors to 9 achieve normoglycemia. Xenotransplantation has thus been used to address 10 the insufficiency in the number of donors (1, 2) , and many studies have been 11 performed to refine the method for resolving the hypofunction of transplanted 12 grafts (3-11). 13 It is well known that a deficiency of zinc affects the onset and exacerbation of 14 diabetes (12) because zinc plays important roles in the synthesis, storage and 15 secretion of insulin, as well as β cell death leading to the occurrence of type 1 16 diabetes. Several studies have demonstrated that increasing the level of 17 dietary zinc can prevent the development of diabetes in animal models (13) (14) (15) . This study was designed to investigate whether dietary zinc supplementation 5 to the donor can improve the results of islet transplantation in chemically 6 induced diabetic rats. Male Wistar rats (SLC, Shizuoka, Japan) weighing 250-300 g were used in 4 this study. They were housed one per plastic cage on sawdust bedding and 5 kept at 24±2℃ and 50±20% humidity with a 12-hour light-dark cycle. The 6 rats were fed a CE-2 pelleted diet (Clea Japan, Tokyo, Japan) and provided 7 drinking water ad libitum. The animals were checked daily throughout the 8 experiments. All experiments were conducted according to the Guidelines for 9 Animal Experimentation of Nagasaki University.
10
Zinc supplementation 11 The donor rats were divided into three groups according to the regimen of 12 dietary zinc supplementation, i.e., a standard pelleted diet containing zinc at 13 50 ppm (control group, n=10), a zinc-poor diet containing zinc at 1 ppm 14 (Low-Zn group, n=10) or zinc-rich diet containing zinc at 1,000 ppm (High-Zn 15 group, n=10). The animals received the dietary zinc supplementation for two 16 weeks prior to extirpation of the pancreas. The non-fasting blood glucose levels of the recipient rats were measured daily 8 to monitor the function of the islet grafts for seven days after transplantation. The recipient rats were then sacrificed, and the serum insulin values and the 10 serum zinc levels were measured.
11
Statistics 12 Unpaired Student's t-test was used for the statistical analyses of the 13 differences in the serum and pancreatic zinc levels, the blood glucose levels 14 and the serum insulin levels among the groups. A P value of less than 0.05 15 was regarded as being statistically significant. Serum and pancreatic zinc levels, and serum insulin values of the donor rats 3 The zinc levels in the serum and pancreatic tissues of the donor rats were 4 significantly different among the three groups ( Table 1 ). The serum and 5 pancreatic zinc levels of the donor rats in the Low-Zn group were significantly 6 lower than those observed in the controls (p<0.05). Conversely, the serum and 7 pancreatic zinc levels in the High-Zn group were significantly higher than Islet graft function 13 The blood glucose levels of the recipient rats measured before and after islet 14 transplantation are shown in Figure 1 . Elevated blood glucose levels greater 15 than 350 mg/dl in the recipient rats following the STZ treatment decreased to 16 less than 150 mg/dl immediately after islet transplantation. However, the 17 blood glucose levels re-elevated two days after islet transplantation in the rats 18 that received islet grafts from the controls or the Low-Zn diet donors. Especially in the rats receiving islets from Low-Zn diet donor rats, the blood 1 glucose levels were extremely high, ranging from 350 to 400 mg/dl. In contrast, 2 in the rats receiving islets from High-Zn diet donors, the blood glucose levels 3 were well maintained within a normal range between 150 and 200 mg/dl 4 throughout the experiment. The blood glucose levels of the rats receiving 5 islets from High-Zn donors were maintained at significantly low levels seven 6 days after islet transplantation compared to those observed in the rats 7 receiving islets from Low-Zn donors (p<0.01). 8 The serum insulin levels in the recipient rats seven days after islet 9 transplantation are shown in Table 2 . The rats that received islets from 10 High-Zn diet donors demonstrated significantly high levels of serum insulin 11 (3.0±1.5 ng/ml) in contrast to those observed in the rats receiving islet 12 transplantation from the controls (1.7±0.7 ng/ml) or low-Zn diet donors 13 (0.8±0.5 ng/ml) (p<0.05). Meanwhile, the serum zinc levels of recipients at the This study demonstrated the effects of zinc on rat islet transplantation using 18 dietary zinc supplementation to donor rats for two weeks prior to donation. 1 The serum and pancreatic zinc levels and the serum insulin levels of the donor 2 rats were increased according to the degree of zinc supplementation. 3 Furthermore, the results of the islet function of islet transplantation were also 4 improved. The blood glucose levels were lower in the High-Zn group than 5 those observed in the control and Low-Zn groups, and the serum insulin levels 6 were also higher in the High-Zn group than those observed in the control and 7 Low-Zn groups. 8 It is also known that islet β cells are vulnerable to oxidative stress (13) . It is 9 suspected that excess free radical production may contribute to the death of β 10 cells and lead to the onset of type 1 diabetes (25-28). Pancreatic islets also lack 11 antioxidant protection (29,30), rendering them especially susceptible to 12 damage by free radicals produced during inflammatory and immune processes. reinforcing the islet function and preventing graft loss through IBMIR. 13 The High-Zn diet donors ate more and grew more compared with the controls. 14 However, food consumption and transitions in body weight did not differ 15 significantly among the groups (data not shown). We thus did not think that 16 any side effects of the High-Zn diet were apparent throughout the experiment.
17
Zinc is considered to be relatively non-toxic to humans (39) . Table 2 Serum Low-Zn group Control group High-Zn group *p<0.01 at day 7.
